Watch stocks you care about
The single, easiest way to keep track of all the stocks that matter...
Your own personalized stock watchlist!
It's a 100% FREE Motley Fool service...
What would you like with your coffee? Cream? Sugar? A bar of silver?
Investopedia reported earlier this week on some investments that would have made you rich in 2009. The big winner in stocks: Diedrich Coffee (Nasdaq: DDRX ) , with a year-to-date return of 9,500%. But if commodities are more to your taste, you could have pocketed a tidy 51% with the iShares Silver Trust ETF (NYSE: SLV ) . Gold? We don't need no stinking gold! You also could have fueled up to the tune of 70% with the United States Gasoline Fund (NYSE: UGA ) .
The BRIC nations would have had you sitting pretty, too. Two Chinese stocks and two Chinese IPOs could have netted you anywhere from 89% to 399%, and leading the mutual fund charge were one Russian fund and two Latin American offerings -- one of which, ProFunds Ultra Latin America, has nine of its top 10 holdings in Brazil, including Petrobras (NYSE: PBR ) and Vale (NYSE: VALE ) .
Naturally, no one knows what the future holds, and it's easy in retrospect to see where the lucrative investments were. But these 2009 hotshots suggest that you can make money even in tough times, if you just know where to look.
What parts of the investing world do you think might hold similar rewards in 2010? Let us know what you see for the future in the comments box below. For each post you make, the Fool will donate $0.10 to the Thurgood Marshall Academy in Washington, D.C., in furtherance of financial literacy.
RSS Headlines
Fool UK
Comments from our Foolish Readers
Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the
Report this Comment icon found on every comment.
Be the first one to comment on this article.